Flucetorex

Last updated
Flucetorex
Flucetorex structure.svg
Identifiers
  • 2-(4-acetamidophenoxy)-N-[1-[3-(trifluoromethyl)phenyl]propan-2-yl]acetamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C20H21F3N2O3
Molar mass 394.394 g·mol−1
3D model (JSmol)
  • CC(CC1=CC(=CC=C1)C(F)(F)F)NC(=O)COC2=CC=C(C=C2)NC(=O)C
  • InChI=1S/C20H21F3N2O3/c1-13(10-15-4-3-5-16(11-15)20(21,22)23)24-19(27)12-28-18-8-6-17(7-9-18)25-14(2)26/h3-9,11,13H,10,12H2,1-2H3,(H,24,27)(H,25,26)
  • Key:SKWBJBJQEUEFCY-UHFFFAOYSA-N

Flucetorex (INN) is an amphetamine. It was investigated as an anorectic, but does not appear to have been marketed. [1] [2] It is related to fenfluramine. [3] [4]

See also

Related Research Articles

<span class="mw-page-title-main">Obesity</span> Medical condition in which excess body fat harms health

Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it negatively affects health. People are classified as obese when their body mass index (BMI)—a person's weight divided by the square of the person's height—is over 30 kg/m2; the range 25–30 kg/m2 is defined as overweight. Some East Asian countries use lower values to calculate obesity. Obesity is a major cause of disability and is correlated with various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis.

<span class="mw-page-title-main">Epidemic</span> Rapid spread of disease affecting a large number of people in a short time

An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.

<span class="mw-page-title-main">Halothane</span> General anaesthetic

Halothane, sold under the brand name Fluothane among others, is a general anaesthetic. It can be used to induce or maintain anaesthesia. One of its benefits is that it does not increase the production of saliva, which can be particularly useful in those who are difficult to intubate. It is given by inhalation.

Human body weight is a person's mass or weight.

An international nonproprietary name (INN) is an official generic and nonproprietary name given to a pharmaceutical drug or an active ingredient. INNs are intended to make communication more precise by providing a unique standard name for each active ingredient, to avoid prescribing errors. The INN system has been coordinated by the World Health Organization (WHO) since 1953.

<span class="mw-page-title-main">Etynodiol</span> Chemical compound

Etynodiol, or ethynodiol, is a steroidal progestin of the 19-nortestosterone group which was never marketed. A diacylated derivative, etynodiol diacetate, is used as a hormonal contraceptive. Etynodiol is sometimes used as a synonym for etynodiol diacetate.

<span class="mw-page-title-main">Febarbamate</span> Chemical compound

Febarbamate, also known as phenobamate, is an anxiolytic and tranquilizer of the barbiturate and carbamate families which is used in Europe by itself and as part of a combination drug formulation called tetrabamate.

<span class="mw-page-title-main">Tolufazepam</span> Chemical compound

Tolufazepam is a drug that is a benzodiazepine derivative. Studies have shown tolufazepam to have anticonvulsant and anxiolytic activity in animal subjects, including convulsions elicited by pentylenetetrazol.

<span class="mw-page-title-main">Aloracetam</span> Chemical compound

Aloracetam (INN) is a drug described as a nootropic which is closely related to, but technically not of, the racetam family of compounds. It was studied by Aventis for the treatment of Alzheimer's disease, but was never marketed.

<span class="mw-page-title-main">Berefrine</span> Sympathomimetic and mydriatic agent

Berefrine, also known as burefrine, is a sympathomimetic and mydriatic agent that was never marketed. It is an oxazolidine prodrug of phenylephrine, and hence, an α1-adrenergic receptor agonist.

<span class="mw-page-title-main">Pivenfrine</span> Chemical compound

Pivenfrine (INN), also known as pivalylphenylephrine, is a sympathomimetic and mydriatic agent.

<span class="mw-page-title-main">Morforex</span> Chemical compound

Morforex, also referable to as N-morpholinoethylamphetamine, is an anorectic which was never marketed.

<span class="mw-page-title-main">Picilorex</span> Chemical compound

Picilorex is an anorectic which is no longer marketed. It is a monoamine reuptake inhibitor, a stimulant as well as a derivate of Pyrrolidine.

<span class="mw-page-title-main">Acridorex</span> Amphetamine

Acridorex is an amphetamine which was investigated as an anorectic but does not appear to have ever been marketed.

<span class="mw-page-title-main">Oxifentorex</span> Chemical compound

Oxifentorex (INN) is an amphetamine described as an anorectic which does not appear to have ever been marketed.

<span class="mw-page-title-main">Fenisorex</span> Chemical compound

Fenisorex is an amphetamine-like anorectic drug which does not appear to have ever been marketed.

<span class="mw-page-title-main">Metaglycodol</span> Chemical compound

Metaglycodol (INN) is a drug described as a tranquilizer which was never marketed.

<span class="mw-page-title-main">Perafensine</span> Chemical compound

Perafensine (INN) is a drug which was investigated as an antidepressant but was never marketed. It has been reported to antagonize the effects of reserpine and to inhibit the reuptake of norepinephrine ; whether it also affects the reuptake of serotonin or dopamine is unclear.

<span class="mw-page-title-main">Pipoxizine</span> Chemical compound

Pipoxizine (INN) is a first-generation antihistamine as well as serotonin antagonist of the diphenylmethylpiperazine group related to hydroxyzine. It was investigated as a bronchodilator but was never marketed.

<span class="mw-page-title-main">Amelometasone</span> Chemical compound

Amelometasone is a synthetic glucocorticoid corticosteroid which was never marketed.

References

  1. ↑ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 568–. ISBN   978-0-412-46630-4.
  2. ↑ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN   978-0-11-986227-0.
  3. ↑ Bray GA (1 July 1980). Obesity: comparative methods of weight control. Technomic. ISBN   978-0-87762-261-1.
  4. ↑ Sullivan AC (1976). "Chapter 21: Agents for the Treatment of Obesity". Annual Reports in Medicinal Chemistry Volume 11. Vol. 11. pp. 200–208. doi:10.1016/S0065-7743(08)61404-9. ISBN   9780120405114. ISSN   0065-7743.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.